Hematologic Malignancies Market - Global Outlook and Forecast 2021-2027

Code: RW00014561915
Market Monitor Global
Oct-2021
Life Sciences
91 Pages

This report contains market size and forecasts of Hematologic Malignancies in Global, including the following market information:
Global Hematologic Malignancies Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Hematologic Malignancies market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hematologic Malignancies companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hematologic Malignancies Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Hematologic Malignancies Market Segment Percentages, By Type, 2020 (%)
Leukemia
Lymphoma
Multiple Myeloma
Others

China Hematologic Malignancies Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Hematologic Malignancies Market Segment Percentages, By Application, 2020 (%)
Chemotherapy
Radiotherapy
Immunotherapy
Stem Cell Transplantation
Others

Global Hematologic Malignancies Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Hematologic Malignancies Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Hematologic Malignancies Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Hematologic Malignancies Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Pfizer, Inc.
F. Hoffmann-LA Roche ltd
Sanofi-Aventis
Bristol-Myers Squibb Company
AbbVie, Inc.
Novartis AG
GlaxoSmithKline PLC
Celgene Corporation
Johnson & Johnson Services, Inc.
Takeda Pharmaceutical Company limited

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Hematologic Malignancies Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hematologic Malignancies Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hematologic Malignancies Overall Market Size
2.1 Global Hematologic Malignancies Market Size: 2021 VS 2027
2.2 Global Hematologic Malignancies Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hematologic Malignancies Players in Global Market
3.2 Top Global Hematologic Malignancies Companies Ranked by Revenue
3.3 Global Hematologic Malignancies Revenue by Companies
3.4 Top 3 and Top 5 Hematologic Malignancies Companies in Global Market, by Revenue in 2020
3.5 Global Companies Hematologic Malignancies Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hematologic Malignancies Players in Global Market
3.6.1 List of Global Tier 1 Hematologic Malignancies Companies
3.6.2 List of Global Tier 2 and Tier 3 Hematologic Malignancies Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Hematologic Malignancies Market Size Markets, 2021 & 2027
4.1.2 Leukemia
4.1.3 Lymphoma
4.1.4 Multiple Myeloma
4.1.5 Others
4.2 By Type - Global Hematologic Malignancies Revenue & Forecasts
4.2.1 By Type - Global Hematologic Malignancies Revenue, 2016-2021
4.2.2 By Type - Global Hematologic Malignancies Revenue, 2022-2027
4.2.3 By Type - Global Hematologic Malignancies Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hematologic Malignancies Market Size, 2021 & 2027
5.1.2 Chemotherapy
5.1.3 Radiotherapy
5.1.4 Immunotherapy
5.1.5 Stem Cell Transplantation
5.1.6 Others
5.2 By Application - Global Hematologic Malignancies Revenue & Forecasts
5.2.1 By Application - Global Hematologic Malignancies Revenue, 2016-2021
5.2.2 By Application - Global Hematologic Malignancies Revenue, 2022-2027
5.2.3 By Application - Global Hematologic Malignancies Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Hematologic Malignancies Market Size, 2021 & 2027
6.2 By Region - Global Hematologic Malignancies Revenue & Forecasts
6.2.1 By Region - Global Hematologic Malignancies Revenue, 2016-2021
6.2.2 By Region - Global Hematologic Malignancies Revenue, 2022-2027
6.2.3 By Region - Global Hematologic Malignancies Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Hematologic Malignancies Revenue, 2016-2027
6.3.2 US Hematologic Malignancies Market Size, 2016-2027
6.3.3 Canada Hematologic Malignancies Market Size, 2016-2027
6.3.4 Mexico Hematologic Malignancies Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Hematologic Malignancies Revenue, 2016-2027
6.4.2 Germany Hematologic Malignancies Market Size, 2016-2027
6.4.3 France Hematologic Malignancies Market Size, 2016-2027
6.4.4 U.K. Hematologic Malignancies Market Size, 2016-2027
6.4.5 Italy Hematologic Malignancies Market Size, 2016-2027
6.4.6 Russia Hematologic Malignancies Market Size, 2016-2027
6.4.7 Nordic Countries Hematologic Malignancies Market Size, 2016-2027
6.4.8 Benelux Hematologic Malignancies Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Hematologic Malignancies Revenue, 2016-2027
6.5.2 China Hematologic Malignancies Market Size, 2016-2027
6.5.3 Japan Hematologic Malignancies Market Size, 2016-2027
6.5.4 South Korea Hematologic Malignancies Market Size, 2016-2027
6.5.5 Southeast Asia Hematologic Malignancies Market Size, 2016-2027
6.5.6 India Hematologic Malignancies Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Hematologic Malignancies Revenue, 2016-2027
6.6.2 Brazil Hematologic Malignancies Market Size, 2016-2027
6.6.3 Argentina Hematologic Malignancies Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hematologic Malignancies Revenue, 2016-2027
6.7.2 Turkey Hematologic Malignancies Market Size, 2016-2027
6.7.3 Israel Hematologic Malignancies Market Size, 2016-2027
6.7.4 Saudi Arabia Hematologic Malignancies Market Size, 2016-2027
6.7.5 UAE Hematologic Malignancies Market Size, 2016-2027
7 Players Profiles
7.1 Pfizer, Inc.
7.1.1 Pfizer, Inc. Corporate Summary
7.1.2 Pfizer, Inc. Business Overview
7.1.3 Pfizer, Inc. Hematologic Malignancies Major Product Offerings
7.1.4 Pfizer, Inc. Hematologic Malignancies Revenue in Global (2016-2021)
7.1.5 Pfizer, Inc. Key News
7.2 F. Hoffmann-LA Roche ltd
7.2.1 F. Hoffmann-LA Roche ltd Corporate Summary
7.2.2 F. Hoffmann-LA Roche ltd Business Overview
7.2.3 F. Hoffmann-LA Roche ltd Hematologic Malignancies Major Product Offerings
7.2.4 F. Hoffmann-LA Roche ltd Hematologic Malignancies Revenue in Global (2016-2021)
7.2.5 F. Hoffmann-LA Roche ltd Key News
7.3 Sanofi-Aventis
7.3.1 Sanofi-Aventis Corporate Summary
7.3.2 Sanofi-Aventis Business Overview
7.3.3 Sanofi-Aventis Hematologic Malignancies Major Product Offerings
7.3.4 Sanofi-Aventis Hematologic Malignancies Revenue in Global (2016-2021)
7.3.5 Sanofi-Aventis Key News
7.4 Bristol-Myers Squibb Company
7.4.1 Bristol-Myers Squibb Company Corporate Summary
7.4.2 Bristol-Myers Squibb Company Business Overview
7.4.3 Bristol-Myers Squibb Company Hematologic Malignancies Major Product Offerings
7.4.4 Bristol-Myers Squibb Company Hematologic Malignancies Revenue in Global (2016-2021)
7.4.5 Bristol-Myers Squibb Company Key News
7.5 AbbVie, Inc.
7.5.1 AbbVie, Inc. Corporate Summary
7.5.2 AbbVie, Inc. Business Overview
7.5.3 AbbVie, Inc. Hematologic Malignancies Major Product Offerings
7.5.4 AbbVie, Inc. Hematologic Malignancies Revenue in Global (2016-2021)
7.5.5 AbbVie, Inc. Key News
7.6 Novartis AG
7.6.1 Novartis AG Corporate Summary
7.6.2 Novartis AG Business Overview
7.6.3 Novartis AG Hematologic Malignancies Major Product Offerings
7.6.4 Novartis AG Hematologic Malignancies Revenue in Global (2016-2021)
7.6.5 Novartis AG Key News
7.7 GlaxoSmithKline PLC
7.7.1 GlaxoSmithKline PLC Corporate Summary
7.7.2 GlaxoSmithKline PLC Business Overview
7.7.3 GlaxoSmithKline PLC Hematologic Malignancies Major Product Offerings
7.4.4 GlaxoSmithKline PLC Hematologic Malignancies Revenue in Global (2016-2021)
7.7.5 GlaxoSmithKline PLC Key News
7.8 Celgene Corporation
7.8.1 Celgene Corporation Corporate Summary
7.8.2 Celgene Corporation Business Overview
7.8.3 Celgene Corporation Hematologic Malignancies Major Product Offerings
7.8.4 Celgene Corporation Hematologic Malignancies Revenue in Global (2016-2021)
7.8.5 Celgene Corporation Key News
7.9 Johnson & Johnson Services, Inc.
7.9.1 Johnson & Johnson Services, Inc. Corporate Summary
7.9.2 Johnson & Johnson Services, Inc. Business Overview
7.9.3 Johnson & Johnson Services, Inc. Hematologic Malignancies Major Product Offerings
7.9.4 Johnson & Johnson Services, Inc. Hematologic Malignancies Revenue in Global (2016-2021)
7.9.5 Johnson & Johnson Services, Inc. Key News
7.10 Takeda Pharmaceutical Company limited
7.10.1 Takeda Pharmaceutical Company limited Corporate Summary
7.10.2 Takeda Pharmaceutical Company limited Business Overview
7.10.3 Takeda Pharmaceutical Company limited Hematologic Malignancies Major Product Offerings
7.10.4 Takeda Pharmaceutical Company limited Hematologic Malignancies Revenue in Global (2016-2021)
7.10.5 Takeda Pharmaceutical Company limited Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Hematologic Malignancies Market Opportunities & Trends in Global Market
Table 2. Hematologic Malignancies Market Drivers in Global Market
Table 3. Hematologic Malignancies Market Restraints in Global Market
Table 4. Key Players of Hematologic Malignancies in Global Market
Table 5. Top Hematologic Malignancies Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Hematologic Malignancies Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Hematologic Malignancies Revenue Share by Companies, 2016-2021
Table 8. Global Companies Hematologic Malignancies Product Type
Table 9. List of Global Tier 1 Hematologic Malignancies Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hematologic Malignancies Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

Pfizer, Inc.
F. Hoffmann-LA Roche ltd
Sanofi-Aventis
Bristol-Myers Squibb Company
AbbVie, Inc.
Novartis AG
GlaxoSmithKline PLC
Celgene Corporation
Johnson & Johnson Services, Inc.
Takeda Pharmaceutical Company limited

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE